Guangdong Zhongsheng Pharmaceutical Co Ltd Price, Chart & Factor Exposure
Free Data & Analytics AccessGuangdong Zhongsheng Pharmaceutical Co Ltd Price Chart
Guangdong Zhongsheng Pharmaceutical Co Ltd Factors
YoY —
YoY −2.3%
YoY −17.0%
YoY +36.3%
YoY −3.7%
YoY −221.9%
YoY —
YoY −16.1%
YoY +19.5%
YoY +97.1%
YoY +16.6%
YoY +14.6%
YoY −277.8%
YoY −100.0%
YoY +100.0%
YoY −6.5%
Guangdong Zhongsheng Pharmaceutical Co Ltd fundamentals: income statement, balance sheet & cash flow
Guangdong Zhongsheng Pharmaceutical Co Ltd reported revenue of 2.52bn CNY and net income of 275.8m CNY in FY2025, the year ended 31 December 2025 — revenue up 2.2% and net income up 192.2% on the prior year. Free cash flow was -11.0m CNY. These figures are as reported in the filings, not restated: 20 fiscal years and 73 quarters of history, back to December 2006.
| CNY millions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 2,522.7 | 2,467.4 | 2,610.6 | 2,676.2 | 2,429.1 |
| Cost of revenue | 1,107.0 | 1,135.4 | 1,081.2 | 941.6 | 813.7 |
| Gross profit | 1,415.7 | 1,332.0 | 1,529.4 | 1,734.6 | 1,615.3 |
| Research & development | 91.0 | 116.8 | 127.4 | 156.6 | 136.7 |
| Selling, general & admin. | — | 1,495.2 | 1,103.3 | 1,203.7 | 1,166.0 |
| Operating income | 320.6 | -280.0 | 298.7 | 374.3 | 312.7 |
| EBITDA | 426.4 | 322.5 | 465.1 | 477.9 | 462.4 |
| Interest expense | 5.0 | 26.2 | 47.4 | 74.2 | 73.8 |
| Pre-tax income | 296.6 | -335.9 | 283.7 | 368.3 | 309.5 |
| Income tax | — | 38.1 | 33.8 | 53.0 | 34.8 |
| Net income | 275.8 | -299.2 | 263.3 | 322.1 | 277.6 |
Download Guangdong Zhongsheng Pharmaceutical Co Ltd fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.2317.SHE&statement=all&freq=a&format=csv&years=10
Figures in CNY, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Guangdong Zhongsheng Pharmaceutical Co Ltd
Explore MacroFinance macro & markets research and analysis.
Guangdong Zhongsheng Pharmaceutical Co Ltd Trading Strategies
28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Guangdong Zhongsheng Pharmaceutical Co Ltd; 2 of them are invested now. Strategies currently invested are listed first.
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
About Guangdong Zhongsheng Pharmaceutical Co Ltd (China)
Guangdong Zhongsheng Pharmaceutical Co Ltd is a listed security in China. This page shows the latest price and daily change, a price chart, its factor exposures, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Guangdong Zhongsheng Pharmaceutical Co Ltd
Frequently asked questions
What is Guangdong Zhongsheng Pharmaceutical Co Ltd?
What factors affect Guangdong Zhongsheng Pharmaceutical Co Ltd?
Which trading strategies trade Guangdong Zhongsheng Pharmaceutical Co Ltd?
Where can I download free Guangdong Zhongsheng Pharmaceutical Co Ltd historical data?
Free Guangdong Zhongsheng Pharmaceutical Co Ltd historical data (last 10 years)
Browse or instantly download the last 10 years of Guangdong Zhongsheng Pharmaceutical Co Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.2317.SHE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 21.81 |
| 2026-11-19 | 23.4 |
| 2026-11-18 | 23.86 |
| 2026-11-17 | 24.48 |
| 2026-11-16 | 24.72 |
| 2026-11-13 | 25.67 |
| 2026-11-12 | 25.72 |
| 2026-11-11 | 25.22 |
| 2026-11-10 | 25.2 |
| 2026-11-09 | 25.3 |
About this stock
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.